A HOUSE RESOLUTION TO RECOGNIZE MARCH 2026 AS "CHRONIC KIDNEY DISEASE AWARENESS MONTH" IN SOUTH CAROLINA IN ORDER TO RAISE AWARENESS OF THE NEED FOR RESEARCH, SCREENING PROGRAMS, AND ACCESS TO CARE FOR INDIVIDUALS WHO SUFFER FROM CHRONIC KIDNEY DISEASE.View full text
Chronic Kidney Disease Awareness Month
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This resolution designates March 2026 as ‘Chronic Kidney Disease Awareness Month’ in South Carolina. The purpose of this designation is to increase public awareness of chronic kidney disease (CKD), the need for research, screening programs, and improved access to care for those affected by the condition. It highlights the significant number of Americans affected by CKD and the importance of early diagnosis.
Key provisions
- Designates March 2026 as Chronic Kidney Disease Awareness Month in South Carolina.
- Aims to raise awareness of chronic kidney disease.
- Calls for increased research, screening programs, and access to care.
- Acknowledges the prevalence of CKD in the United States (approximately 37 million Americans).
- Highlights the often-undiagnosed nature of CKD, with 90% of those with stages 1-3 being unaware.
- Mentions specific causes of CKD, including hypertension, heart disease, and glomerulonephritis.
- Notes the potential for rapid progression to end-stage renal disease (ESRD) in patients with glomerular diseases.
Who is affected
- Individuals with chronic kidney disease (CKD)
- Healthcare providers and organizations involved in kidney disease treatment
- The general public of South Carolina
Notable changes
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours